In their Q2 earnings call, $OSS noted that top-line growth was "primarily driven by increased sales of liquid-cooled server products to a medical imaging OEM supporting a breast cancer screening application."
As I mentioned in my post ahead of $QTI earnings, I wanted to dig into
